These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 28677802

  • 1. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 2. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T, Meng Q, Han J, Sun H, Li L, Song R, Sun B, Pan S, Liang D, Liu L.
    Oncotarget; 2016 Jul 12; 7(28):43475-43491. PubMed ID: 27259268
    [Abstract] [Full Text] [Related]

  • 3. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 Jul 12; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

  • 4. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C, Guo F, Xu G, Ma J, Shao F.
    Oncol Rep; 2015 Apr 12; 33(4):1872-82. PubMed ID: 25653024
    [Abstract] [Full Text] [Related]

  • 5. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
    Ren J, Li G, Zhao W, Lin L, Ye T.
    World J Gastroenterol; 2016 Apr 21; 22(15):3962-8. PubMed ID: 27099439
    [Abstract] [Full Text] [Related]

  • 6. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway.
    Liu K, Tian T, Zheng Y, Zhou L, Dai C, Wang M, Lin S, Deng Y, Hao Q, Zhai Z, Dai Z.
    J Cell Mol Med; 2019 Apr 21; 23(4):3040-3044. PubMed ID: 30697962
    [Abstract] [Full Text] [Related]

  • 7. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y, Yuan T, Wang WW, Ge PL, Gao ZQ, Zhang G, Tang Z, Dang XW, Zhao YF, Zhang JY, Jiang GZ.
    Cell Physiol Biochem; 2018 Apr 21; 51(1):301-314. PubMed ID: 30453302
    [Abstract] [Full Text] [Related]

  • 8. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
    Gong QZ, Xiao D, Gong GY, Xu J, Wen XD, Feng F, Qu W.
    Curr Cancer Drug Targets; 2019 Apr 21; 19(7):583-593. PubMed ID: 30585547
    [Abstract] [Full Text] [Related]

  • 9. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.
    Yeh CB, Hsieh MJ, Hsieh YH, Chien MH, Chiou HL, Yang SF.
    PLoS One; 2012 Apr 21; 7(2):e31055. PubMed ID: 22363545
    [Abstract] [Full Text] [Related]

  • 10. STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang CH, Guo FL, Xu GL, Jia WD, Ge YS.
    Hepatogastroenterology; 2014 Jun 21; 61(132):1082-9. PubMed ID: 26158169
    [Abstract] [Full Text] [Related]

  • 11. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
    Huang C, Yang G, Jiang T, Zhu G, Li H, Qiu Z.
    Neoplasma; 2011 Jun 21; 58(5):396-405. PubMed ID: 21744993
    [Abstract] [Full Text] [Related]

  • 12. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.
    Yao RR, Li JH, Zhang R, Chen RX, Wang YH.
    World J Surg Oncol; 2018 Jan 16; 16(1):9. PubMed ID: 29338742
    [Abstract] [Full Text] [Related]

  • 13. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S, Okumura N, Wei L, Fuchs BC, Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK, Kodera Y.
    Ann Surg Oncol; 2014 Nov 16; 21(12):3882-90. PubMed ID: 24833103
    [Abstract] [Full Text] [Related]

  • 14. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F, Wang S, Wei Y, Wu J, Huang G, Chen J, Shi J, Xia J.
    Biomed Pharmacother; 2018 Jul 16; 103():1092-1100. PubMed ID: 29710674
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J.
    Biomed Pharmacother; 2018 Oct 16; 106():134-141. PubMed ID: 29957463
    [Abstract] [Full Text] [Related]

  • 16. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H.
    Sci Rep; 2017 Jan 30; 7():41616. PubMed ID: 28134289
    [Abstract] [Full Text] [Related]

  • 17. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY.
    Biomed Pharmacother; 2018 Feb 30; 98():214-221. PubMed ID: 29268242
    [Abstract] [Full Text] [Related]

  • 18. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 30; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 19. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
    Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, Hsu SL.
    Int J Cancer; 2002 Jul 10; 100(2):158-65. PubMed ID: 12115564
    [Abstract] [Full Text] [Related]

  • 20. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):1247-1254. PubMed ID: 27091428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.